🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
FENOC is a prospective, open-label, randomized, cross-over, multi-center st...
Status
Completed
Location
Malmo University Hospital
Start Date
2000-07
Trial ID
NCT00166309
Treatments Being Tested
The purpose of the aPCC-emicizumab safety study is to investigate the hemos...
Status
Recruiting
Location
Children's Healthcare of Atlanta
Start Date
2026-09
Trial ID
NCT04563520
Treatments Being Tested
This is a non-interventional, multicenter, observational, international stu...
Status
Recruiting
Location
Arthur M. Blank Hospital
Start Date
2020-03-17
Trial ID
NCT04023019
Patients with severe hemophilia and inhibitors can be treated effectively b...
Status
Completed
Location
Multiple Locations
Start Date
2005-01
Trial ID
NCT00284193
Treatments Being Tested
Activated prothrombin complex concentrate (aPCC) and recombinant activated ...
Status
Completed
Location
Oslo University Hospital
Start Date
2011-10
Trial ID
NCT01800435
Treatments Being Tested
This trial is conducted in the United States of America (USA). This study c...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2001-09
Trial ID
NCT00108797
Treatments Being Tested
This study is conducted in the United States of America (USA). The aim of t...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2008-06
Trial ID
NCT00710619
Treatments Being Tested
This multicenter, open-label study will evaluate the safety, efficacy and p...
Status
Completed
Location
Children's Hospital Los Angeles
Start Date
2015-11-18
Trial ID
NCT02622321
Treatments Being Tested
This is a multicenter, multinational, open-label, one-way cross-over, Phase...
Status
Active Not Recruiting
Location
Center for Inherited Blood Disorders (CIBD) Site Number : 8400012
Start Date
2023-02-01
Trial ID
NCT05662319